CLL Support Association
8,932 members14,270 posts

Dr. Shpall on Therapeutic Agents for the Treatment of CLL

Elizabeth J. Shpall, MD, professor, deputy department chair, Department of Stem Cell Transplantation, Division of Cancer Medicine, medical director, Cell Therapy Laboratory, director, Cord Blood Bank, the University of Texas MD Anderson Cancer Center, discusses idelalisib and ibrutinib for the treatment of patients with chronic lymphocytic leukemia (CLL).

- See more at:


You may also like...